BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 38101776)

  • 1. [Clinical characteristics and diagnostic indicators of macrophage activation syndrome in patients with systemic lupus erythematosus and adult-onset Still's disease].
    Yao HH; Yang F; Tang SM; Zhang X; He J; Jia Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):966-974. PubMed ID: 38101776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are the 2016 EULAR/ACR/PRINTO classification criteria for macrophage activation syndrome applicable to patients with adult-onset Still's disease?
    Tada Y; Inokuchi S; Maruyama A; Suematsu R; Sakai M; Sadanaga Y; Ono N; Arinobu Y; Koarada S
    Rheumatol Int; 2019 Jan; 39(1):97-104. PubMed ID: 30051293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The performance of the diagnostic scoring system or criteria for macrophage activation syndrome in systemic juvenile idiopathic arthritis for adult-onset Still's disease. A multicentre case-control study in China.
    Yao H; Wang Y; Wang Z; Zhao J; Deng X; Zhang Z; Zhao Y; Zhang Y; Shu Q; Jia Y; Li ZG
    Clin Exp Rheumatol; 2021; 39 Suppl 132(5):129-134. PubMed ID: 34596030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of Interleukin-18 as a Diagnostic Biomarker to Differentiate Adult-Onset Still's Disease With/Without Macrophage Activation Syndrome From Other Secondary Hemophagocytic Lymphohistiocytosis in Adults.
    Shiga T; Nozaki Y; Tomita D; Kishimoto K; Hirooka Y; Kinoshita K; Funauchi M; Matsumura I
    Front Immunol; 2021; 12():750114. PubMed ID: 34691064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disparities in the prevalence of clinical features between systemic juvenile idiopathic arthritis and adult-onset Still's disease.
    Ruscitti P; Natoli V; Consolaro A; Caorsi R; Rosina S; Giancane G; Naddei R; Di Cola I; Di Muzio C; Berardicurti O; Iacono D; Pantano I; Rozza G; Rossi S; De Stefano L; Balduzzi S; Vitale A; Caso F; Costa L; Prete M; Navarini L; Iagnocco A; Atzeni F; Guggino G; Perosa F; Cantarini L; Frediani B; Montecucco C; Ciccia F; Cipriani P; Gattorno M; Giacomelli R; Ravelli A
    Rheumatology (Oxford); 2022 Oct; 61(10):4124-4129. PubMed ID: 35078234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage activation syndrome in systemic lupus erythematosus and systemic-onset juvenile idiopathic arthritis: a retrospective study of similarities and dissimilarities.
    Naveen R; Jain A; Muhammed H; Gupta L; Misra DP; Lawrence A; Agarwal V; Misra R; Aggarwal A
    Rheumatol Int; 2021 Mar; 41(3):625-631. PubMed ID: 33388903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of the 2016 EULAR/ACR/PRINTO Classification Criteria for Macrophage Activation Syndrome in Patients with Adult-onset Still Disease.
    Ahn SS; Yoo BW; Jung SM; Lee SW; Park YB; Song JJ
    J Rheumatol; 2017 Jul; 44(7):996-1003. PubMed ID: 28412707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Assessment of MS-Score and HScore in timeliness of diagnosis of macrophage activation syndrome associated with adult-onset Still's disease].
    Peng Z; Gao XM; Zhou S; Wu CY; Zhao JL; Xu D; Li MT; Peng JM; Li J; Wang Q; Tian XF; Zeng X
    Zhonghua Yi Xue Za Zhi; 2022 Jul; 102(28):2210-2214. PubMed ID: 35872586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage activation syndrome associated with adult-onset Still's disease: a multicenter retrospective analysis.
    Wang R; Li T; Ye S; Tan W; Zhao C; Li Y; de Bao C; Fu Q
    Clin Rheumatol; 2020 Aug; 39(8):2379-2386. PubMed ID: 32130578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences and similarities in cytokine profiles of macrophage activation syndrome in systemic lupus erythematosus and adult-onset Still's disease.
    Hiyama T; Kurasawa K; Hasegawa A; Miyao T; Tanaka A; Arai S; Arima M; Maezawa R
    Clin Exp Med; 2023 Nov; 23(7):3407-3416. PubMed ID: 36611087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of the international league against rheumatism classification criteria for systemic juvenile idiopathic arthritis as a prognostic factor in patients with adults-onset Still's disease.
    Yang JW; Lee E; Seo JY; Jung JY; Suh CH; Kim HA
    Pediatr Rheumatol Online J; 2018 Jan; 16(1):9. PubMed ID: 29370863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline clinical features predicting macrophage activation syndrome in patients with systemic adult-onset Still's disease receiving interleukin-6 inhibitor treatment.
    Naniwa T; Yamabe T; Ohmura SI; Uehara K; Tamechika SY; Maeda S; Isogai S; Wada J
    Int J Rheum Dis; 2022 Sep; 25(9):1003-1012. PubMed ID: 35719030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage activation syndrome in patients with adult-onset Still's disease under tocilizumab treatment: A single-center observational study.
    Yamabe T; Ohmura SI; Uehara K; Naniwa T
    Mod Rheumatol; 2022 Jan; 32(1):169-176. PubMed ID: 33719871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus.
    Aytaç S; Batu ED; Ünal Ş; Bilginer Y; Çetin M; Tuncer M; Gümrük F; Özen S
    Rheumatol Int; 2016 Oct; 36(10):1421-9. PubMed ID: 27510530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage activation syndrome in Still's disease: analysis of clinical characteristics and survival in paediatric and adult patients.
    Ruscitti P; Rago C; Breda L; Cipriani P; Liakouli V; Berardicurti O; Carubbi F; Di Battista C; Verrotti A; Giacomelli R
    Clin Rheumatol; 2017 Dec; 36(12):2839-2845. PubMed ID: 28914368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and initial validation of the MS score for diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis.
    Minoia F; Bovis F; Davì S; Horne A; Fischbach M; Frosch M; Huber A; Jelusic M; Sawhney S; McCurdy DK; Silva CA; Rigante D; Unsal E; Ruperto N; Martini A; Cron RQ; Ravelli A;
    Ann Rheum Dis; 2019 Oct; 78(10):1357-1362. PubMed ID: 31296501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage activation syndrome complicating adult onset Still's disease: A single center case series and comparison with literature.
    Lenert A; Yao Q
    Semin Arthritis Rheum; 2016 Jun; 45(6):711-6. PubMed ID: 26672682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive review on adult onset Still's disease.
    Giacomelli R; Ruscitti P; Shoenfeld Y
    J Autoimmun; 2018 Sep; 93():24-36. PubMed ID: 30077425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult-onset Still's disease in focus: Clinical manifestations, diagnosis, treatment, and unmet needs in the era of targeted therapies.
    Efthimiou P; Kontzias A; Hur P; Rodha K; Ramakrishna GS; Nakasato P
    Semin Arthritis Rheum; 2021 Aug; 51(4):858-874. PubMed ID: 34175791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of macrophage activation syndrome in patients with adult-onset Still's disease with skin involvement: A retrospective cohort study.
    Ding Y; Tang S; Li S; Yang C; Liu T; Ying S; Zhu D; Sun C; Chen W; Shi Y; Fang H; Qiao J
    J Am Acad Dermatol; 2021 Dec; 85(6):1503-1509. PubMed ID: 33556412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.